Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D07OQF
|
|||
Former ID |
DIB019515
|
|||
Drug Name |
PMID25489658C4d
|
|||
Synonyms |
GTPL8483
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1], [2] | |
Structure |
Download2D MOL
|
|||
Formula |
C17H10BrClO4
|
|||
Canonical SMILES |
C1=CC(=CC(=C1)Cl)OC(=O)C2=CC3=C(C=CC(=C3)CBr)OC2=O
|
|||
InChI |
1S/C17H10BrClO4/c18-9-10-4-5-15-11(6-10)7-14(17(21)23-15)16(20)22-13-3-1-2-12(19)8-13/h1-8H,9H2
|
|||
InChIKey |
RNWNTBMGGUARMR-UHFFFAOYSA-N
|
|||
PubChem Compound ID | ||||
PubChem Substance ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Kallikrein-14 (KLK14) | Target Info | Inhibitor | [2] |
Kallikrein-5 (KLK5) | Target Info | Inhibitor | [2] | |
Kallikrein-7 (KLK7) | Target Info | Inhibitor | [2] | |
Suppressor of tumorigenicity 14 protein (ST14) | Target Info | Inhibitor | [2] | |
KEGG Pathway | MicroRNAs in cancer | |||
NetPath Pathway | TCR Signaling Pathway | |||
Reactome | Degradation of the extracellular matrix | |||
WikiPathways | Hair Follicle Development: Cytodifferentiation (Part 3 of 3) |
References | Top | |||
---|---|---|---|---|
REF 1 | Mutations in SPINK5, encoding a serine protease inhibitor, cause Netherton syndrome. Nat Genet. 2000 Jun;25(2):141-2. | |||
REF 2 | Toward the first class of suicide inhibitors of kallikreins involved in skin diseases. J Med Chem. 2015 Jan 22;58(2):598-612. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.